Privia Health Group (PRVA) Projected to Announce Quarterly Earnings on Thursday

Privia Health Group (NASDAQ:PRVA) is expected to be issuing its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect Privia Health Group to post earnings of $0.08 per share and revenue of $597.7370 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 6, 2026 at 8:00 AM ET.

Privia Health Group Trading Down 2.9%

Shares of NASDAQ PRVA opened at $24.12 on Thursday. The stock’s 50-day moving average is $24.47 and its 200 day moving average is $23.34. The stock has a market cap of $3.04 billion, a price-to-earnings ratio of 150.76, a P/E/G ratio of 1.96 and a beta of 0.83. Privia Health Group has a 1-year low of $18.77 and a 1-year high of $28.82.

Analyst Upgrades and Downgrades

PRVA has been the topic of a number of recent research reports. Evercore set a $26.00 price target on shares of Privia Health Group in a research report on Wednesday, April 8th. Zacks Research lowered shares of Privia Health Group from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 7th. Canaccord Genuity Group decreased their target price on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Barclays decreased their price objective on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 26th. Finally, Citigroup restated a “buy” rating on shares of Privia Health Group in a report on Thursday, July 23rd. Eleven research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Privia Health Group presently has an average rating of “Moderate Buy” and an average price target of $31.15.

Insider Activity at Privia Health Group

In related news, Director Matthew Shawn Morris sold 88,110 shares of the firm’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $25.33, for a total value of $2,231,826.30. Following the completion of the sale, the director owned 76,651 shares of the company’s stock, valued at $1,941,569.83. This trade represents a 53.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Mountcastle sold 24,734 shares of Privia Health Group stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $27.50, for a total transaction of $680,185.00. Following the completion of the sale, the chief financial officer owned 186,728 shares in the company, valued at approximately $5,135,020. This trade represents a 11.70% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 478,855 shares of company stock worth $12,099,109 over the last quarter. 5.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Privia Health Group

Large investors have recently modified their holdings of the stock. Global Retirement Partners LLC raised its stake in Privia Health Group by 579.8% in the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after buying an additional 1,351 shares in the last quarter. Canada Pension Plan Investment Board increased its stake in shares of Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after purchasing an additional 1,200 shares in the last quarter. Kestra Advisory Services LLC purchased a new position in shares of Privia Health Group during the fourth quarter valued at approximately $93,000. Raymond James Financial Inc. purchased a new position in shares of Privia Health Group during the second quarter valued at approximately $113,000. Finally, Acadian Asset Management LLC bought a new stake in shares of Privia Health Group in the 1st quarter worth approximately $154,000. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.